Welcome to our dedicated page for IQVIA HOLDINGS SEC filings (Ticker: IQV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on IQVIA HOLDINGS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into IQVIA HOLDINGS's regulatory disclosures and financial reporting.
IQVIA Holdings Inc. (IQV) filed a Form 4 showing that Senior Vice President & Corporate Controller Keriann Cherofsky sold 549 common shares on 07/23/2025 at $191.53 per share, a transaction valued at roughly $105k. After the sale, her direct ownership stands at 2,910 shares; no derivative securities were involved.
The disposition reduced her direct stake by about 16% (549 of ~3,459 prior shares). While small relative to IQV’s market capitalization and daily trading volume, insider sales can be perceived as a modestly bearish signal because executives possess superior insight into company prospects. No accompanying purchases, option exercises, or material company events were reported in this filing.
IQVIA Holdings Inc. (IQV) – Form 144 filing discloses a proposed insider sale of common stock under Rule 144.
- Securities offered: 5,800 common shares
- Estimated market value: $1,102,262.16 (≈ $190 per share)
- Broker: Morgan Stanley Smith Barney LLC, New York
- Planned sale date: 23 Jul 2025 on the NYSE
- Total shares outstanding: 170 million; proposed sale equals <0.01% of float
- Source of shares: Stock Appreciation Rights acquired on 23 Jul 2025; consideration paid in cash
The filer states no material non-public adverse information is known. No other sales were made in the past three months. Given the small size relative to IQVIA’s float and the absence of accompanying operational data, the notice is unlikely to affect valuation or liquidity materially.